Greenwood, IN, United States of America

Wu-Kuang Yeh

This inventor holds 5 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1988-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wu-Kuang Yeh. Retrieved from https://idiyas.com/inventor/wu-kuang-yeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1988-1998

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Wu-Kuang Yeh: Pioneering Advances in Enzyme Purification

Introduction

Wu-Kuang Yeh, a distinguished inventor based in Greenwood, IN, has made significant contributions to the field of enzyme purification with a total of five patents to his name. His expertise is primarily focused on the purification processes of various enzymes, which hold substantial implications for pharmaceutical developments.

Latest Patents

Among his latest innovations, Yeh's first patent addresses the purification of Deacetoxycephalosporin C hydroxylase. This enzyme is meticulously purified from crude cell-free extracts through a series of sophisticated techniques including chromatography over a weak anionic exchange resin, ammonium sulfate fractionation, gel filtration, hydroxylapatite chromatography, and FPLC. Remarkably, this process yields the enzyme in over 90% purity, showcasing Yeh's commitment to achieving high standards in enzyme isolation. Furthermore, he elucidates specific amino-terminal sequences that contribute to the functionality of the hydroxylase, which efficiently converts DAOC to DAC, along with additional enzymatic reactions.

Another noteworthy patent from Yeh involves the process for purifying Echinocandin B deacylase. This enzyme is extracted from Actinoplanes utahensis and refined through a series of precise steps, including heating, hydrophobic interaction chromatography, and multiple stages of gel filtration and cation exchange chromatography, ultimately achieving near homogeneity. This innovation is crucial for advancing the production of echinocandin compounds, which are fundamental in antifungal treatments.

Career Highlights

Wu-Kuang Yeh is currently associated with Eli Lilly and Company, a prominent player in the pharmaceutical industry, where his inventions play a vital role in developing new drug therapies. Over the years, his efforts in enzyme purification have garnered recognition and respect among his peers and the scientific community.

Collaborations

Yeh has collaborated with notable coworkers, including Joe E Dotzlaf and Adam Joseph Kreuzman. Together, they contribute to advancements in enzyme technology and create solutions that enhance pharmaceutical research processes.

Conclusion

In conclusion, Wu-Kuang Yeh stands out as a notable inventor whose work in enzyme purification is shaping the landscape of pharmaceutical innovations. With his impressive portfolio of patents and collaborations, he continues to pave the way for advancements that benefit both the scientific community and society at large.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…